Last reviewed · How we verify

The Influence of High-Dose Aprotinin and Tranexamic Acid on Bleeding Tendency and Allogeneic Blood Transfusion in Patients Undergoing Primary Aortic Valve Replacement or Coronary Artery Revascularization

NCT00396760 Phase 3 UNKNOWN

The hypothesis of this study is that the antifibrinolytic drugs aprotinin and tranexamic acid equally influence bleeding tendency and transfusion requirement in patients undergoing first time cardiac procedures with a low risk of increased postoperative bleeding.Only patients undergoing first time CABG or first time aortic valve replacement are included in this study.

Details

Lead sponsorGerman Heart Center
PhasePhase 3
StatusUNKNOWN
Enrolment220
Start date2005-01
Completion2006-07

Conditions

Interventions

Primary outcomes

Countries

Germany